Complement factor H Y402H polymorphism results in diminishing CD4+ T cells and increasing C-reactive protein in plasma
Authors:
Open Access
- 8 November 2023
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-9
Abstract
Age-related macular degeneration (AMD) is a common cause of visual loss among the elderly. Genetic variants in the gene encoding complement factor H (CFH) have been identified as an AMD susceptibility gene, however, the mechanistic link is debated. Here, we investigated the link between the CFH Y402H genotype and low-grade inflammation. We recruited 153 healthy individuals, 84 participants with dry stages of AMD, and 148 participants with neovascular AMD. All participants were subjected to detailed retinal examination, and interview regarding comorbidities and lifestyle. Blood samples were analyzed for level of C-Reactive Protein (CRP), white blood cell differential count, and stained with fluorescent antibodies to differentiate CD4+ and CD8+ T cells. CFH Y402H genotyping was performed using an allele-specific polymerase chain reaction genotyping assay. Splenocytes from young and aged wild type and Cfh null mutant C57BL/6J mice were examined for CD4+ and CD8+ T cells. Healthy individuals with the CFH Y402H at-risk polymorphism HH had higher levels of CRP and lower proportions of CD4+ T cells compared to persons with the YH or YY polymorphism (P = 0.037, Chi-square). Healthy individuals with the HH polymorphism displayed lower proportions of CD4+ T cells with ageing (P < 0.01, one-way ANOVA), whereas both young and aged Cfh null mutant mice displayed lower proportions of CD4+ T cells (P < 0.001 and P < 0.05; unpaired t test). Participants with dry AMD and the HH polymorphism had similarly lower proportions of CD4+ T cells (P = 0.024, one-way ANOVA), but no difference in CRP-levels. In the neovascular stage of AMD, there was no difference in proportion of CD4+ cells or CRP levels according to genotype. The risk-associated CFH genotype is associated with an age-related decrease in proportion of CD4+ T cells and increased levels of CRP in healthy individuals. This indicates that decreased complement regulation results in extensive changes in innate and adaptive immune compartments that precede development of AMD.Keywords
Funding Information
- Velux Fonden
- Fight for Sight Denmark
- Region Zealand
- Synoptik-Fonden
This publication has 36 references indexed in Scilit:
- Retinal pigment epithelial cells upregulate expression of complement factors after co-culture with activated T cellsExperimental Eye Research, 2011
- Plasma Complement Components and Activation Fragments: Associations with Age-Related Macular Degeneration Genotypes and PhenotypesInvestigative Ophthalmology & Visual Science, 2009
- Reference Values for CD4+ and CD8+ T Lymphocytes with Naïve or Memory Phenotype and Their Association with Mortality in the ElderlyGerontology, 2009
- Systemic Complement Activation in Age-Related Macular DegenerationPLOS ONE, 2008
- The immune risk profile is associated with age and gender: findings from three Swedish population studies of individuals 20–100 years of ageBiogerontology, 2008
- Complement Factor H polymorphism Y402H associates with inflammation, visual acuity, and cardiovascular mortality in the elderly population at largeExperimental Gerontology, 2007
- T-cell regulation: with complements from innate immunityNature Reviews Immunology, 2006
- Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroidProceedings of the National Academy of Sciences, 2006
- Evaluation of the Clinical Age-Related Maculopathy Staging SystemOphthalmology, 2006
- Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor HNature Genetics, 2002